The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jan. 14, 2025
Filed:
Dec. 28, 2022
Applicant:
Nutramax Laboratories, Inc., Lancaster, SC (US);
Inventors:
Todd Henderson, Lancaster, SC (US);
David Griffin, Forest Hill, MD (US);
David Bledsoe, Lancaster, SC (US);
Assignee:
Nutramax Laboratories, Inc., Lancaster, SC (US);
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 31/198 (2006.01); A61K 9/00 (2006.01); A61K 31/197 (2006.01); A61K 31/4045 (2006.01); A61K 31/7076 (2006.01); A61K 36/575 (2006.01); A61K 36/756 (2006.01); A61K 38/01 (2006.01); A61K 38/38 (2006.01); A61K 45/06 (2006.01);
U.S. Cl.
CPC ...
A61K 31/198 (2013.01); A61K 9/0053 (2013.01); A61K 31/197 (2013.01); A61K 31/4045 (2013.01); A61K 31/7076 (2013.01); A61K 36/575 (2013.01); A61K 36/756 (2013.01); A61K 38/018 (2013.01); A61K 38/38 (2013.01); A61K 45/06 (2013.01);
Abstract
An anxiolytic composition formulated for oral administration to a mammal includes a synergistic combination of L-theanine, at least one ofand an extract of, and at least one ofand an extract of. The composition may include a combination of an extract ofand a extract of. The synergistic combination may provide an anxiolytic change in a release pattern of one or more brain neurotransmitters, such as glutamate and/or γ-aminobutyric acid (GABA).